Lilong Liu
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 5
- Cancer-related molecular mechanisms research 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- Immunology top 10%
-
- Ferroptosis and cancer prognosis 5
- Renal cell carcinoma treatment 4
- Inhalation and Respiratory Drug Delivery 4
-
- Bladder and Urothelial Cancer Treatments 6
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Junyi HuYaxin HouKe ChenLijie ZhouMing XiongZhaohui ChenYu YangZhen Tao
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nature Communications (2 papers)Nature Genetics (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lilong Liu
43 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 319
- Oncology 348
- Immunology 244
- Molecular Biology 624
- Pulmonary and Respiratory Medicine 289
Countries citing papers authored by Lilong Liu
This map shows the geographic impact of Lilong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilong Liu more than expected).
Fields of papers citing papers by Lilong Liu
This network shows the impact of papers produced by Lilong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilong Liu. The network helps show where Lilong Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lilong Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 46 | |
| 8 | 2022 | 41 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 7 | |
| 13 | Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinomabreakdown → | 2020 | 412 |
| 14 | 2020 | 16 | |
| 15 | 2020 | 121 | |
| 16 | Sensitivity of hull-less pumpkin powdery mildew to five kinds of triazole fungicides. | 2019 | 1 |
| 17 | 2019 | 4 | |
| 18 | 2018 | 1 | |
| 19 | Response of yield,nitrogen uptake in Jiyou716 to nitrogen management under different tillage patterns | 2013 | 3 |
| 20 | 2013 | 3 |
About Lilong Liu
Lilong Liu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Biological Psychiatry, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (5 papers), Renal cell carcinoma treatment (4 papers), COVID-19 Clinical Research Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (319 citations), Oncology (348 citations) and Immunology (244 citations). Lilong Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Junyi Hu, Yaxin Hou, Ke Chen, Lijie Zhou, Ming Xiong, Zhaohui Chen, Yu Yang, Zhen Tao, Jing Yang and Xuewei Chen. Their work appears in journals such as Nature Communications, Nature Genetics and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.